National Postdoctoral Researcher
Program of China, Grant/Award Number:
GZC20231800; National Natural Science
Foundation of China, Grant/Award
Numbers: 82270720, 32171301; Project of
Science and Technology Department of
Sichuan Province, Grant/Award
Numbers: 2023YFS0029, 2015SZ0230-2,
24NSFSC3172
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
无
最新[2023]版:
大类|1 区医学
小类|2 区医学:研究与实验2 区肿瘤学
第一作者:
第一作者机构:[1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, P.R. China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Di Xingpeng,Chen Jiawei,Li Ya,et al.Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials[J].Clinical And Translational Medicine.2024,14(1):e1545.doi:10.1002/ctm2.1545.
APA:
Di Xingpeng,Chen Jiawei,Li Ya,Wang Menghua,Wei Jingwen...&Luo Deyi.(2024).Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials.Clinical And Translational Medicine,14,(1)
MLA:
Di Xingpeng,et al."Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials".Clinical And Translational Medicine 14..1(2024):e1545